The Department of Psychiatry at NYU Langone is a world leader in research, with a long-standing mission of improving the mental health and wellbeing of adult patients experiencing a wide range of psychiatric illnesses. Our researchers are based at NYU Langone’s Tisch Hospital and the The Nathan S. Kline Institute for Psychiatric Research. Our department fosters the career development of physician–scientists in addition to PhD researchers from many associated disciplines. Tanya C. Sippy, MD, PhD, director of research track for the residency training program in psychiatry, and Naomi M. Simon, MD, PhD, vice chair for faculty development and engagement, lead this effort.

NYU Grossman School of Medicine is No. 8 in the country in National Institutes of Health research funding, according to Blue Ridge Institute.

Our department’s extensive research initiatives and resources reflect this ranking. Our scientific investigations encompass the following areas:

• adult attention deficit hyperactivity disorder
• anxiety, stress, and prolonged grief
• alcohol use disorder and traumatic stress
• brain aging and sleep
• computational research
• decision-making and reward
• dementia and neurodegenerative disease
• epidemiology
• mood disorders and cognition
• neuroscience
• obsessive–compulsive disorder
• post-traumatic stress disorder
• psychedelic medicine
• schizophrenia
• substance use disorder

Among our many research resources is the world-class NYU Druckenmiller Neuroscience Institute, an extensive array of MRI and PET imaging platforms along with advanced imaging processing pipelines and computational resources, a 9.4T MRI under development at the Nathan Kline Institute, a dedicated research sleep lab, the Tech4Health Bioengineering Program to support innovations in neuromodulation, and a departmental biostatistics team dedicated to improving the way in which clinical trials can inform precision medicine.  NYU Langone also offers a wide range of scientific cores and shared resources, including the Clinical and Translational Science Institute.

Investigators in our department play leadership roles in many areas. Among them are the pioneering of new models for the etiology of Alzheimer’s disease, the therapeutic application of psychedelics, new methods of neuromodulation and precision medicine approaches to the treatment of PTSD and schizophrenia based on novel biomarkers and computational methods. All these efforts inform and advance patient care and make our department an excellent place for medical students, residents, fellows, doctoral students, and postgraduates to receive research training in psychiatry.